Skip to main content
Year archive

BOTANIX PHARMACEUTICALS LTD — 2020 filings

All 42 regulatory filings released by BOTANIX PHARMACEUTICALS LTD (BOT) in 2020, sourced directly from the official regulator.

42 Filings
2020 Period
2020 filings (42)
Filing Released Lang
Appendix 2A and Notice Under Section 708A 16 pages 285.1KB
Regulatory Filings
2020-12-16 English
Update on BTX 1801 Phase 2a Clinical Study 2 pages 175.9KB
Regulatory Filings
2020-12-13 English
AGM Presentation 21 pages 2.3MB
Regulatory Filings
2020-11-22 English
Results of Meeting 2 pages 128.1KB
Regulatory Filings
2020-11-22 English
FDA Clears Development Path for BTX 1801 3 pages 198.8KB
Regulatory Filings
2020-11-10 English
Notice of Annual General Meeting/Proxy Form 21 pages 983.8KB
Regulatory Filings
2020-10-20 English
Letter to Shareholders - AGM 3 pages 857.8KB
Regulatory Filings
2020-10-20 English
Appendix 4C - Quarterly 9 pages 366.0KB
Regulatory Filings
2020-10-12 English
Response to ASX Price Query 4 pages 726.6KB
Regulatory Filings
2020-09-28 English
Annual Report to Shareholders with Revised Top 20 71 pages 929.3KB
Regulatory Filings
2020-09-07 English
New Antimicrobial Data and Conference Presentation 20 pages 1.8MB
Regulatory Filings
2020-09-07 English
Appendix 4E and Annual Report to Shareholders 73 pages 1.1MB
Regulatory Filings
2020-08-30 English
Appendix 4G 11 pages 187.5KB
Regulatory Filings
2020-08-30 English
BTX 1801 Phase 2a Antimicrobial Study Underway 3 pages 194.0KB
Regulatory Filings
2020-08-11 English
Appendix 4C - Quarterly 9 pages 336.4KB
Regulatory Filings
2020-07-29 English
Response to ASX Aware Query 5 pages 760.0KB
Regulatory Filings
2020-07-21 English
BTX 1503 End of Phase 2 Milestone with FDA 3 pages 167.0KB
Regulatory Filings
2020-07-16 English
Appendix 3G 13 pages 305.6KB
Regulatory Filings
2020-06-30 English
Change of Director's Interest Notice * 4 9 pages 386.6KB
Regulatory Filings
2020-06-30 English
Botanix Provides Update on Development Activities 3 pages 165.6KB
Regulatory Filings
2020-06-23 English
Results of Meeting 2 pages 140.5KB
Regulatory Filings
2020-06-23 English
Amended Constitution 61 pages 583.7KB
Regulatory Filings
2020-06-23 English
Notice of General Meeting/Proxy Form 33 pages 1.1MB
Regulatory Filings
2020-05-21 English
Letter to Shareholders - General Meeting 3 pages 861.4KB
Regulatory Filings
2020-05-21 English
Change of Director's Interest Notice MT 2 pages 200.9KB
Regulatory Filings
2020-05-10 English
Appendix 4C - Quarterly 10 pages 312.8KB
Regulatory Filings
2020-04-29 English
FDA Grants BTX 1801 QIDP Designation Status 4 pages 283.5KB
Regulatory Filings
2020-04-23 English
Botanix Provides Update on Development Activities 5 pages 251.3KB
Regulatory Filings
2020-04-15 English
Botanix Provides Update on Development Activities Amended 5 pages 263.3KB
Regulatory Filings
2020-04-15 English
Proposed issue of Securities - BOT 6 pages 30.3KB
Regulatory Filings
2020-04-15 English
Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data 4 pages 226.6KB
Regulatory Filings
2020-03-24 English
Trading Halt 2 pages 222.0KB
Regulatory Filings
2020-03-23 English
Antimicrobial Platform Update and Launch of BTX 1801 Study 29 pages 6.1MB
Regulatory Filings
2020-03-12 English
Cowen Conference and Additional BTX 1503 Data Analysis 29 pages 2.6MB
Regulatory Filings
2020-03-03 English
Half Yearly Report and Accounts 26 pages 951.6KB
Regulatory Filings
2020-02-27 English
Change of Director's Interest Notice SW 3 pages 225.6KB
Regulatory Filings
2020-02-24 English
Botanix Board Update 2 pages 136.1KB
Regulatory Filings
2020-02-10 English
Initial Director's Interest Notice MC 2 pages 138.4KB
Regulatory Filings
2020-02-10 English
Final Director's Interest Notice RT 2 pages 207.5KB
Regulatory Filings
2020-02-10 English
Appendix 4C - Quarterly 9 pages 368.3KB
Regulatory Filings
2020-01-30 English
Botanix receives A$7.6m R&D Tax Incentive refund 2 pages 161.0KB
Regulatory Filings
2020-01-28 English
Botanix Attends USA Healthcare Conferences 32 pages 1.5MB
Regulatory Filings
2020-01-12 English